Gene · 5169
Papers2,209
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,209
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) - a promising target for the immunotherapy of cancer. | Front Immunol | 2023 | 37711611 | PubTator, text mining | PubMed |
| Mother's knowledge for environmental risks and self-awareness for the presence of pollutants in her living area in West and Central Anatolia: a cross-sectional survey. | BMC Public Health | 2023 | 37710255 | PubTator, text mining | PubMed |
| Initial experience of thoracoscopic segmentectomy of basal segment through the inferior pulmonary ligament approach in treating congenital lung malformations in children. | BMC Pediatr | 2023 | 37704985 | PubTator, text mining | PubMed |
| Complex Karyotype Acute Basophilic Leukemia with Reactive Mast Cell Hyperplasia. | Clin Lab | 2023 | 37702688 | PubTator, text mining | PubMed |
| Dynamic single-cell regulomes characterize human peripheral blood innate lymphoid cell subpopulations. | iScience | 2023 | 37694139 | PubTator, text mining | PubMed |
| Using organoids to investigate human endometrial receptivity. | Front Endocrinol (Lausanne) | 2023 | 37693361 | PubTator, text mining | PubMed |
| Elevation of Metrnβ and Its Association with Disease Activity in Systemic Lupus Erythematosus. | Int J Mol Sci | 2023 | 37686413 | PubTator, text mining | PubMed |
| Micro-inflammation related gene signatures are associated with clinical features and immune status of fibromyalgia. | J Transl Med | 2023 | 37670381 | PubTator, text mining | PubMed |
| Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study. | Blood Cancer J | 2023 | 37666856 | PubTator, text mining | PubMed |
| Cell-targeted vaccines: implications for adaptive immunity. | Front Immunol | 2023 | 37662903 | PubTator, text mining | PubMed |
| Phylogenetic inference of the emergence of sequence modules and protein-protein interactions in the ADAMTS-TSL family. | PLoS Comput Biol | 2023 | 37651409 | PubTator, text mining | PubMed |
| Isovalent electronic systems B+13 and BeB12: structural interchange of GM and TS. | Phys Chem Chem Phys | 2023 | 37646793 | PubTator, text mining | PubMed |
| Structural Evolution and Electronic Properties of Two Sulfur Atom-Doped Boron Clusters. | ACS Omega | 2023 | 37636960 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates: Ushering in a New Era of Cancer Therapy. | Pharmaceutics | 2023 | 37631232 | PubTator, text mining | PubMed |
| Tools for Etiologic Diagnosis of Drug-Induced Allergic Conditions. | Int J Mol Sci | 2023 | 37628756 | PubTator, text mining | PubMed |
| Estimating Time-Varying Treatment Switching Effect Using Accelerated Failure Time Model with Application to Vascular Access for Hemodialysis. | Commun Stat Theory Methods | 2023 | 37588769 | PubTator, text mining | PubMed |
| Targeted Nanofitin-drug Conjugates Achieve Efficient Tumor Delivery and Therapeutic Effect in an EGFRpos Mouse Xenograft Model. | Mol Cancer Ther | 2023 | 37578807 | PubTator, text mining | PubMed |
| Theoretical and semi-analytical simulation for a two-predator-one-prey model during the mating period. | PLoS One | 2023 | 37556454 | PubTator, text mining | PubMed |
| Allergenicity of partially hydrolyzed whey and casein formulas evaluated by ImmunoCAP inhibition assay and basophil activation test. | Front Allergy | 2023 | 37546176 | PubTator, text mining | PubMed |
| A DFT study to investigate the physical, electrical, optical properties and thermodynamic functions of boron nanoclusters (MxB2n0; x=1,2, n=3,4,5). | Heliyon | 2023 | 37539100 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5169/papers?page=8